Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 35

1.

The use of the exploratory IND in the evaluation and development of 18F-PET radiopharmaceuticals for amyloid imaging in the brain: a review of one company's experience.

Carpenter AP Jr, Pontecorvo MJ, Hefti FF, Skovronsky DM.

Q J Nucl Med Mol Imaging. 2009 Aug;53(4):387-93. Review.

PMID:
19834448
[PubMed - indexed for MEDLINE]
Free Article
2.

Florbetapir (18F), a PET imaging agent that binds to amyloid plaques for the potential detection of Alzheimer's disease.

Okamura N, Yanai K.

IDrugs. 2010 Dec;13(12):890-9. Review.

PMID:
21154149
[PubMed - indexed for MEDLINE]
3.

Development and evaluation of compounds for imaging of beta-amyloid plaque by means of positron emission tomography.

Henriksen G, Yousefi BH, Drzezga A, Wester HJ.

Eur J Nucl Med Mol Imaging. 2008 Mar;35 Suppl 1:S75-81. doi: 10.1007/s00259-007-0705-x. Review.

PMID:
18224319
[PubMed - indexed for MEDLINE]
4.

[Molecular PET imaging for in vivo detection of amyloid in the human brain].

Okamura N.

Rinsho Shinkeigaku. 2009 Nov;49(11):922-4. Review. Japanese.

PMID:
20030249
[PubMed - indexed for MEDLINE]
5.

[Molecular imaging of beta-amyloid plaques in the brain].

Ono M.

Brain Nerve. 2007 Mar;59(3):233-40. Review. Japanese.

PMID:
17370649
[PubMed - indexed for MEDLINE]
6.

(18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.

Vallabhajosula S.

Semin Nucl Med. 2007 Nov;37(6):400-19. Review.

PMID:
17920348
[PubMed - indexed for MEDLINE]
7.

Impact of amyloid imaging on drug development in Alzheimer's disease.

Mathis CA, Lopresti BJ, Klunk WE.

Nucl Med Biol. 2007 Oct;34(7):809-22. Epub 2007 Sep 4. Review.

PMID:
17921032
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

[Positron emission tomography: contribution to diagnosis of dementia and development of disease-modifying drugs].

Ito K, Kato T.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2009 Aug;29(4):153-60. Review. Japanese.

PMID:
19764482
[PubMed - indexed for MEDLINE]
9.

Florbetaben to trace amyloid-β in the Alzheimer brain by means of PET.

Barthel H, Sabri O.

J Alzheimers Dis. 2011;26 Suppl 3:117-21. doi: 10.3233/JAD-2011-0068. Review.

PMID:
21971456
[PubMed - indexed for MEDLINE]
10.

Development of Alzheimer's disease imaging agents for clinical studies.

Ryu EK, Chen X.

Front Biosci. 2008 Jan 1;13:777-89. Review.

PMID:
17981587
[PubMed - indexed for MEDLINE]
11.

Visualizing pathology deposits in the living brain of patients with Alzheimer's disease.

Kepe V, Huang SC, Small GW, Satyamurthy N, Barrio JR.

Methods Enzymol. 2006;412:144-60. Review.

PMID:
17046657
[PubMed - indexed for MEDLINE]
12.

The role of positron emission tomography imaging of beta-amyloid in patients with Alzheimer's disease.

Xiong KL, Yang QW, Gong SG, Zhang WG.

Nucl Med Commun. 2010 Jan;31(1):4-11. Review.

PMID:
19972633
[PubMed - indexed for MEDLINE]
13.

[Molecular imaging by PET/SPECT].

Ono M.

Yakugaku Zasshi. 2009 Mar;129(3):279-87. Review. Japanese.

PMID:
19252385
[PubMed - indexed for MEDLINE]
Free Article
14.

[Significance of imaging biomarkers in exploratory clinical trials].

Takano H, Suhara T.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2009 Apr;29(2):55-9. Review. Japanese.

PMID:
19562942
[PubMed - indexed for MEDLINE]
15.
16.

Imaging Alzheimer's disease pathology: one target, many ligands.

Lockhart A.

Drug Discov Today. 2006 Dec;11(23-24):1093-9. Epub 2006 Oct 30. Review.

PMID:
17129828
[PubMed - indexed for MEDLINE]
17.

Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer's disease.

Foster NL, Wang AY, Tasdizen T, Fletcher PT, Hoffman JM, Koeppe RA.

Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S29-36. doi: 10.1016/j.jalz.2007.10.004. Epub 2007 Dec 21. Review.

PMID:
18631997
[PubMed - indexed for MEDLINE]
18.

Amyloid imaging: from benchtop to bedside.

Wu C, Pike VW, Wang Y.

Curr Top Dev Biol. 2005;70:171-213. Review.

PMID:
16338342
[PubMed - indexed for MEDLINE]
19.

Recent progress in fluorine-18 labelled peptide radiopharmaceuticals.

Okarvi SM.

Eur J Nucl Med. 2001 Jul;28(7):929-38. Review.

PMID:
11504093
[PubMed - indexed for MEDLINE]
20.

Radiopharmaceuticals for brain imaging.

Saha GB, MacIntyre WJ, Go RT.

Semin Nucl Med. 1994 Oct;24(4):324-49. Review.

PMID:
7817203
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk